{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} More Than a New Name: Updates in the Management of Clostridioides difficile Infections

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe etiology, risk factors, and transmission of CDI.
  2. Describe diagnostic testing for CDI.
  3. Explain treatment and management strategies for patients diagnosed with CDI.

Learning Outcomes

A majority of participants in this activity will demonstrate knowledge of Clostridioides difficile infection (CDI) management by achieving a passing score on the posttest.
Price: $21.95

Credits:

  • ANCC 2.0 CH / 0.5 APH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Awarded Advanced Pharmacology Hours













Test Code: NP0824A
Published: Aug 2024
Expires: 9/5/2025
Required Passing Score: 8/10 (80%)
Authors: Alexander F. Wrynn, DNP, FNP-C